In addition to the attention focused on drug/drug interactions such as those in drug distribution, drug metabolism, drug absorption, and receptor binding in multiple-drug therapy, 1-4) drug/metabolite interaction(s) in the biopharmaceutical fate of drugs was reported. 5-10) Studenberg and Brouwer reported that the metabolites of phenobarbital inhibited the biotransformation of acetaminophen (APAP). 11) We also reported the effects of the concomitant use of N-acetyl-paminophenol O-sulfate (APAPS, as potassium salt) [12] [13] [14] and its geometric isomers 15) with their parent drug, APAP. In those reports, it was found that the tissue-to-plasma concentration ratio (K p ) of APAP was significantly increased in the liver, heart, kidney, and brain in the presence of APAPS but not by its geometric isomers. That is, APAPS appears to play a role as a biodistribution promoter. A similar phenomenon was observed when 4-hydroxyantipyrine was concomitantly administered with antipyrine. 16) The evaluation of glutathionesulfonic acid sodium salt [N-(N-g-L-glutamyl-L-bsulfoalanyl)glycine sodium salt, GSO 3 Na] 17,18) as a biodistribution promoter was also carried out with verapamil hydrochloride and tegafur. 19) 
described above. Five minutes after its administration, blood was collected from the abdominal aorta, and the rats were decapitated immediately. Tissue samples of the heart, lung, brain, liver, kidney, and spleen were extirpated and homogenized (30000 rpm, PRO 250, PRO Scientific Inc. Monroe, CT, U.S.A.) in isotonic phosphate buffer (pH 7.4) for 1 min. Five milliliters of ethyl acetate was added to 1 ml of the homogenate and the mixture was shaken for 1 h. After centrifugation (3000 rpm, 10 min, 4°C), 4 ml of the upper layer was collected and evaporated in vacuo. The residue was dissolved in 300 ml of the mobile-phase solvent for HPLC measurement. Saline was used as a control.
In Vitro Experiments Effect of GSO 3 Na on Protein Binding of Thiopental Sodium: Bovine serum albumin (BSA) was dissolved in saline (final concentration was 100 nmol/ml) and preincubated at 37°C for 2 min. One hundred microliters of the solution of thiopental sodium in saline (final concentration 20 mg/ml) was added to 400 ml of the BSA solution and the mixture was incubated at 37°C for 5 min. After incubation, the mixture was immediately ultrafiltrated through ULTRAFREE C3LGC (Japan Millipore, Tokyo). The filtrate was diluted with methanol (5-fold volume of the filtrate). The concentration of the unbound drug was determined by HPLC measurement. The final concentration was 1 mmol/ml for thiopental sodium containing 0-5 mmol/ml of GSO 3 Na.
Effect of GSO 3 Na on Affinity of Thiopental Sodium to Tissue: After exsanguination under urethane anesthesia (900 mg/kg, i.p.), saline (50-fold volume of the organ) was added to each organ (brain, lung, and liver) and the mixture was homogenized. Two hundred microliters of the drug solution (final concentration 20 mg/ml) was added to 800 ml of the homogenate (final concentration 1 mmol/ml). After shaking for 15 s and centrifugation (12000ϫg and 10 min), the supernatant was immediately ultrafiltrated through ULTRAFREE C3LGC. The filtrate was diluted with methanol (7-fold volume). The determination was performed by HPLC measurement. This experiment was carried out at low temperature (2-3°C).
Effect of GSO 3 Na and GSH on Apparent Partition Coefficient of Thiopental Sodium: A mixture of 4 ml of n-octanolsaturated phosphate buffer solution (50 mM, pH 7.4) containing 1 mmol/ml of thiopental sodium and 1-10 mmol/ml of GSO 3 H (or GSH) and 4 ml of n-octanol which was saturated with 50 mM phosphate buffer solution (pH 7.4) was vigorously shaken at room temperature for 30 min. Then the mixture was shaken slowly at 37°C for 2 h. The upper layer (noctanol layer) was diluted with methanol and the aqueous layer was diluted with purified water. The concentration of thiopental sodium was determined by HPLC measurement.
Analytical Method The reverse-phase HPLC measurement for the detection of thiopental sodium was performed according to our previous reports. 12, 14, 16) Briefly, an HPLC apparatus (LC-10AD, Shimadzu, Kyoto, Japan) was connected with a Wakopak column (Wakosil-II 5C18, 4.6 mm i.d.ϫ150 mm, Wako Pure Chemical Industries, Ltd., Osaka, Japan) and an UV detector (SPD-10A, Shimadzu) operated at 289 nm.
Mobile phase was 7.4 mM of phosphate buffer solution (pH 3.0)-acetonitrile (50 : 50, v/v). The flow rate was 1.0 ml/min and injection volumes were all 20 ml. The temperature tested was 40°C. Thiopental sodium was detected as a symmetrical peak.
Five hundred microliters of methanol was added to 100 ml of the plasma sample to denaturalize the protein. After precipitation of protein by centrifugation (3000 rpmϫ10 min), 60 ml of the supernatant filtered through a 0.45-mm pore-size membrane filter (Japan Millipore, Yonezawa, Japan) was injected into the HPLC system for measurement.
Data Analysis Plasma concentrations (C p ) of thiopental sodium after intravenous administration were fitted to a biexponential curve, C p ϭA · exp(Ϫa · t)ϩB · exp(Ϫb · t), by the nonlinear least-squares regression program 20) with a weight of 1/C p . Pharmacokinetic parameters were calculated from the estimated parameters, A, B, a and b, where the area under the plasma concentration time curve (AUC) was calculated from A/aϩB/b and the total body clearance, CL total , was equal to Dose/AUC. The elimination half-life, t 1/2b , was calculated from ln 2/b. The mean residence time, MRT, was calculated as AUMC/AUC, with AUMC meaning the area under the first moment curve. The volume of the central compartment, V d1 , was calculated as Dose/(AϩB). The apparent volume of distribution at steady state, V dss , was calculated as Dose · AUMC/AUC 21, 22) (Fig. 1 ).
K p values of thiopental sodium under the steady state of GSO 3 Na (or GSH) were calculated from C t /C p , with C t and C p meaning the concentrations of thiopental sodium in the tissue and in the plasma, respectively ( Fig. 3 ).
To determine partition coefficients, the initial concentration of thiopental sodium in the aqueous layer and its concentrations in the aqueous and n-octanol layers after equilibrium were determined. The equation is shown by P octanol ϭC octanol /C water ϭ(C o ϪC water )/C water where C octanol and C water are the concentrations of thiopental sodium in the n-octanol and the aqueous layers after equilibrium, respectively, and C o is the initial concentration of thiopental sodium in the aqueous layer.
Statistical Analysis Statistical analyses of the effects of GSO 3 Na (or GSH) on the pharmacokinetic parameters, the K p value, the protein binding, the affinity to tissue, and the apparent partition coefficient of thiopental sodium were performed using Student's t-test. Analysis of variance (ANOVA) with Tukey's multiple comparison procedure was also performed. In all statistical testing, p values less than 0.05 were considered to be statistically significant.
RESULTS

Effect of GSO 3 Na and GSH on Pharmacokinetic Parameters of Thiopental Sodium
Plasma elimination profile of intravenous bolus administration of thiopental sodium (13.2 mg/kg) under the steady-state concentration of GSO 3 Na (or GSH) is apparently biexponential with time and shown in Fig. 2 . Pharmacokinetic parameters of thiopental sodium with concomitant GSO 3 Na (or GSH) were calculated using the pharmacokinetics model ( Fig. 1 ) and are summarized in Table 1 . Almost no significant change by the concomitant use of GSO 3 Na or GSH was recognized in the parameters.
Effect of GSO 3 Na and GSH on K p Value of Thiopental Sodium The K p values of thiopental sodium 5 and 60 min after the intravenous bolus administration of this drug under the steady-state concentration of GSO 3 Na (or GSH) are shown in Fig. 3 . The K p value of thiopental sodium 60 min after the administration increased significantly in all tissues (the heart, lung, brain, liver, kidney, and spleen) by the concomitant use of GSO 3 Na. On the other hand, the value 5 min after administration was significantly decreased in the spleen. GSH did not affect the K p values in any tissues.
Effect of GSO 3 Na on Protein Binding of Thiopental Sodium As shown in Table 2 , approximately 77% of thiopental sodium was bound to BSA. No significant change of this binding ratio was observed by the addition of less than 5-fold GSO 3 Na.
Effect of GSO 3 Na on Affinity of Thiopental Sodium to Tissue As shown in Table 3 , approximately 50-65% of thiopental sodium was bound to the brain, lung, and liver. No significant change of the binding ratio was observed by the addition of GSO 3 Na.
Effect of GSO 3 Na and GSH on Apparent Partition Coefficients of Thiopental Sodium Apparent partition coefficient of thiopental sodium in the presence of GSO 3 Na (or GSH) is shown in Fig. 4 . The coefficient was enhanced with increasing concentration of GSO 3 Na, although it was not affected by GSH.
DISCUSSION
We have reported that the pharmacokinetics of drugs are sometimes influenced by biopharmaceutical interactions with their metabolites. [5] [6] [7] [8] [9] [10] [12] [13] [14] [15] [16] It was also shown that one of the metabolites having sulfonic acid moiety like APAPS and GSO 3 Na could promote the biodistribution of other drugs which were not their parent drug. 16, 19) For further study of the biodistribution promoter using GSO 3 Na, we here employed thiopental sodium as an active drug. Thiopental sodium is well known as a central nervous system drug and an anesthetic-inducing agent.
The plasma elimination profile of intravenously administered thiopental sodium under the steady-state concentration of GSO 3 Na (or GSH) was examined and it was found to be apparently biexponential with time ( Fig. 2) . When GSO 3 Na was coadministered, the plasma concentration of thiopental sodium had a tendency to become high; when GSH was used, its concentration was almost the same as that of control. Next, pharmacokinetic parameters of thiopental sodium under the concomitant use of GSO 3 Na or GSH were calculated using the pharmacokinetics model (Fig. 1) . Almost no significant effect by GSO 3 Na or GSH was recognized in the parameters ( Table 1) . As described below, the K p values of thiopental sodium 60 min after its administration with concomitant GSO 3 Na increased significantly; V dss should also increase. But Table 1 showed the opposite result: the mean value of V dss (778) rather decreased (ca. 85%) than increased.
This reduction seems to come partially from a large scatter of the plasma concentration caused by the individual difference during the transition time. However, we have no clear plausible explanation for this phenomenon at present. Swerdlow et al. reported that V dss and CL total were 1620 ml/kg and 182.4 ml/h, respectively, when thiopental sodium (9.28 mg/kg) was administered to human. 23) The difference between their results and ours seems to come from the species difference between a human and a rat.
The K p value of thiopental sodium 5 min after its administration with concomitant GSO 3 Na significantly decreased in the spleen. No difference was found in other tissues. This phenomenon can be partially explained as follows: the stage 5 min after administration corresponds to a distribution phase (a phase) in the blood pharmacokinetic profile and is in the midst of the distribution. So, the reduction in the K p value in the spleen seemed to be caused by the delay of plasma elimination speed. As the significant change of the K p value was not recognized in other tissues, this distribution effect may specifically occur in the spleen. On the contrary, the K p value 60 min after administration with concomitant GSO 3 Na significantly increased in all tissues. The stage 60 min after administration corresponds to a disappearance phase (b phase) and the equilibrium is established. As described below, GSO 3 Na increased the apparent partition coefficients of thiopental sodium but it could not change the protein binding ratio or affinity to tissues. Therefore, we assume that the elevation of the K p values in all tissues 60 min after administration comes from the enhancement of the apparent partition coefficients that increased the absolute distribution volume of thiopental sodium in all tissues. No significant effect on the K p value by the concomitant use of GSH was recognized in any organ.
In general, an intravenously administered drug must pass through the plasma membrane for distribution to the tissues, and the protein binding ratio and the partition coefficient of the drug are the factors allowing membrane transport. Protein binding ratio of thiopental sodium is comparatively high (72-80% in 10-50 mg/ml ranges of its concentration). [24] [25] [26] [27] Therefore, the effect of GSO 3 Na on the protein binding of thiopental sodium to BSA was evaluated. The protein binding ratio was not changed by the addition of less than 5-fold GSO 3 Na. The effect of GSO 3 Na on the affinity of thiopental sodium to some tissues was also examined, but no difference was found between the concomitant use and no use of GSO 3 Na. So, it seemed that the protein binding was not a factor that could change the K p value of thiopental sodium with concomitant GSO 3 Na. Next, we examined the effects of GSO 3 Na and GSH on the apparent partition coefficient of thiopental sodium. As shown in Fig. 4 , GSO 3 Na enhanced it and GSH did not. This result suggests that the change of the partition coefficient by GSO 3 Na is related to the mechanism of elevation of the K p value of thiopental sodium. One of the factors that can change the partition coefficient of the compound is the salting-out effect. But the concentrations of thiopental sodium and GSO 3 Na are only 1 mM and 1-10 mM, respectively, while 50 mM phosphate buffer solution was employed in our experiment. That is, the salt concentration of the buffer solution is 5-50-fold those of thiopental sodium and GSO 3 Na. So, it would appear very difficult for the migration of a small amount of GSO 3 Na from the water layer to the organic layer to change the partition coefficient under our conditions. Therefore, the salting-out effect can be neglected. At present, it is not clear why the partition coefficient of thiopental sodium increased with the concomitant use of GSO 3 Na. The relationship between the elevation of the K p value and the change of the partition coefficient of thiopental sodium is also not clear. We assume there is some type of interaction between thiopental sodium and GSO 3 Na and this interaction increases the partition coefficient of thiopental sodium and also causes the enhancement of the K p values in the tissues. At present, however, we have no plausible explanation what kind of interaction this is or why this phenomenon occurs.
CONCLUSION
In the present study, it was determined that the concomitant use of GSO 3 Na significantly enhanced the K p values of thiopental sodium 60 min after its administration in the heart, lung, brain, liver, kidney, and spleen, while GSH did not affect them. The elevation of the K p values was assumed to come from the enhancement of the apparent partition coefficient that increases the absolute distribution volume of thiopental sodium in all tissues with concomitant GSO 3 Na. At present we have no plausible explanation for why the partition coefficient of thiopental sodium increases with the concomitant use of GSO 3 Na and what mechanism acts to enhance the K p values.
